RecallDepth
Class II Terminated

Loxapine Capsules, USP 50 mg, Rx Only, 100-count bottles, NDC 0378-7050-01

Company
Mylan Pharmaceuticals Inc.
Recall Initiated
April 24, 2018
Posted
May 30, 2018
Recall Number
D-0825-2018
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
11,650 bottles
Firm Location
Morgantown, WV, United States

Reason for Recall

CGMP Deviations

Distribution

Product was distributed throughout the United States, including Puerto Rico.

Lot / Code Info

NDC 0378-7050-01 Lot Numbers: 3079386, Exp. 10/31/18 3079387, Exp. 10/31/18 3079388, Exp. 10/31/18 3083762, Exp. 3/31/19 3083763, Exp. 3/31/19 3083764, Exp. 3/31/19 3083765, Exp. 3/31/19 3083766, Exp. 3/31/19 3083767, Exp. 3/31/19

More recalls by Mylan Pharmaceuticals Inc.

View all recalls by this company →

Other recent Class II Drug recalls